FDA inspection
ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH: FDA inspection ending Mar 17, 2023
FDA inspection 1202871 · No Action Indicated (NAI) · Radeberg
Key facts
| Inspection ID | 1202871 |
|---|---|
| Firm | ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH |
| FEI number | 3004849998 |
| Address | Heinrich-Glaser-Str. 10-14 |
| City | Radeberg |
| Country | Germany |
| Fiscal year | 2023 |
| Inspection end date | Mar 17, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data